ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

NextGen Healthcare Achieves Two Million Virtual Visits Milestone

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Trend Toward ‘Care Anywhere’ Continues to Grow as Company Sees Nearly 5,000% Increase in Telehealth Visits Since March 2020

NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that it has enabled two million telehealth visits since March 2020, a significant milestone. Providers across the U.S. have relied on NextGen Virtual Visits™ to provide safe and convenient continuity of care during the COVID-19 pandemic, resulting in a nearly 5,000% increase in telehealth visits since last year. The solution quickly became a vital enabler of the patient-provider connection and a critical lifeline for patients with limited access to health services. During this period of rapid growth, NextGen Virtual Visits received high patient satisfaction scores of 9.1 out of 10.

NextGen Virtual Visits integrate seamlessly into NextGen® Enterprise Electronic Health Records (EHR) – a best-in-class solution as designated by KLAS Research this year. This industry-leading platform provides safe, convenient, HIPAA-compliant access to care from virtually anywhere. Providers can see their scheduled and on-demand patients via video as part of their normal workflow. In addition, they can:

  • Manage and refill medications
  • Request images during intake and view during consultation
  • Review lab results, x-rays, and ultrasounds
  • Exchange confidential documents
  • Streamline access to specialties such as behavioral health
  • Minimize missed appointments

“NextGen Healthcare is gratified to have responded so effectively to the growing demand for telehealth. We acquired OTTO Health in December 2019, three months before COVID-19 became a pandemic in the U.S. and demand for virtual visits exploded,” said Srinivas (Sri) Velamoor, chief growth & solution officer for NextGen Healthcare.

Velamoor continued, “Two million virtual visits in just over 18 months represents an exponential increase in scale, and effectiveness of virtual care delivery in ambulatory settings. Importantly, our healthcare platform not only solves near-term access needs, but is presenting opportunities to work with providers to shape how care will be delivered in the future.”

“Virtual visits have been easy to schedule for our patients and have been seamless for our providers to facilitate,” said David A. Glow, director of information systems for Boulder Medical Center and NextGen Healthcare client. “It’s rewarding to know we can meet patients where they are using this technology, and provide virtual access to much-needed care.”

About NextGen Healthcare, Inc.

NextGen Healthcare, Inc. (Nasdaq: NXGN) is a leading provider of ambulatory-focused technology solutions. We are empowering the transformation of ambulatory care—partnering with medical, behavioral and dental providers in their journey to value-based care to make healthcare better for everyone. We go beyond EHR and PM. Our integrated solutions help increase clinical productivity, enrich the patient experience, and ensure healthy financial outcomes. We believe in better. Learn more at nextgen.com, and follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  259.36
-1.76 (-0.67%)
AAPL  270.51
+2.90 (1.08%)
AMD  325.16
-9.47 (-2.83%)
BAC  52.70
+0.07 (0.14%)
GOOG  347.24
-1.28 (-0.37%)
META  671.22
-7.40 (-1.09%)
MSFT  426.24
+1.42 (0.33%)
NVDA  212.78
-3.84 (-1.77%)
ORCL  166.86
-6.10 (-3.53%)
TSLA  377.02
-1.65 (-0.44%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.